ArticleBMC pharmacology & toxicology2025

Ranolazine as a therapeutic agent for diabetic cardiomyopathy: reducing endoplasmic reticulum stress and inflammation in type 2 diabetic rat model.

Matin Mohyadini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.